Genpact Limited Stock Number Of Shares Shorted
G Stock | USD 30.72 0.02 0.07% |
Genpact Limited fundamentals help investors to digest information that contributes to Genpact's financial success or failures. It also enables traders to predict the movement of Genpact Stock. The fundamental analysis module provides a way to measure Genpact's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genpact stock.
Genpact | Number Of Shares Shorted |
Genpact Limited Company Number Of Shares Shorted Analysis
Genpact's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Genpact Number Of Shares Shorted | 5.17 M |
Most of Genpact's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genpact Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Genpact Number Of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for Genpact is extremely important. It helps to project a fair market value of Genpact Stock properly, considering its historical fundamentals such as Number Of Shares Shorted. Since Genpact's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Genpact's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Genpact's interrelated accounts and indicators.
Click cells to compare fundamentals
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Competition |
Based on the recorded statements, Genpact Limited has 5.17 M of outstending shares currently sold short by investors. This is 29.22% higher than that of the IT Services sector and 20.39% lower than that of the Information Technology industry. The number of shares shorted for all United States stocks is 9.86% lower than that of the firm.
Genpact Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genpact's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genpact could also be used in its relative valuation, which is a method of valuing Genpact by comparing valuation metrics of similar companies.Genpact is currently under evaluation in number of shares shorted category among related companies.
Genpact Current Valuation Drivers
We derive many important indicators used in calculating different scores of Genpact from analyzing Genpact's financial statements. These drivers represent accounts that assess Genpact's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Genpact's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 8.0B | 7.9B | 10.0B | 8.5B | 6.3B | 3.6B | |
Enterprise Value | 9.4B | 9.1B | 11.0B | 9.6B | 7.2B | 3.9B |
Genpact Fundamentals
Return On Equity | 0.31 | |||
Return On Asset | 0.083 | |||
Profit Margin | 0.14 % | |||
Operating Margin | 0.14 % | |||
Current Valuation | 6.47 B | |||
Shares Outstanding | 180.33 M | |||
Shares Owned By Insiders | 1.00 % | |||
Shares Owned By Institutions | 98.58 % | |||
Number Of Shares Shorted | 5.17 M | |||
Price To Earning | 28.59 X | |||
Price To Book | 2.50 X | |||
Price To Sales | 1.26 X | |||
Revenue | 4.48 B | |||
Gross Profit | 1.54 B | |||
EBITDA | 630.86 M | |||
Net Income | 631.25 M | |||
Cash And Equivalents | 646.76 M | |||
Cash Per Share | 2.53 X | |||
Total Debt | 1.5 B | |||
Debt To Equity | 1.04 % | |||
Current Ratio | 1.58 X | |||
Book Value Per Share | 12.53 X | |||
Cash Flow From Operations | 490.81 M | |||
Short Ratio | 2.94 X | |||
Earnings Per Share | 3.41 X | |||
Price To Earnings To Growth | 1.70 X | |||
Target Price | 37.0 | |||
Number Of Employees | 129.1 K | |||
Beta | 1.07 | |||
Market Capitalization | 5.54 B | |||
Total Asset | 4.81 B | |||
Retained Earnings | 1.09 B | |||
Working Capital | 573.58 M | |||
Current Asset | 1.2 B | |||
Current Liabilities | 594.48 M | |||
Annual Yield | 0.02 % | |||
Five Year Return | 0.90 % | |||
Net Asset | 4.81 B | |||
Last Dividend Paid | 0.55 |
About Genpact Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genpact Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genpact using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genpact Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Genpact Piotroski F Score and Genpact Altman Z Score analysis. Note that the Genpact Limited information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Genpact Stock analysis
When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.311 | Dividend Share 0.55 | Earnings Share 3.41 | Revenue Per Share 24.552 | Quarterly Revenue Growth 0.04 |
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.